Thereasa Rich
Thereasa Rich spoke at National Society of Genetic Counselors (NSGC) Annual Conference 2026 in November 2026 (speaker, “Demystifying MRD: The Genetic Counselor’s Role in ctDNA-Based Cancer Monitoring and Minimal Residual Disease Detection”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Thereasa. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Thereasa is a certified genetic counselor with 20 years of experiencing working in oncology genetics/epigenetics. She is currently a Sr. Clinical Evidence Director at Guardant Health, where she is responsible for leading the generation of clinical evidence needed to address clinical unmet needs and to support product development, commercialization, reimbursement, regulatory approval, and adoption for new product initiatives at Guardant Health with a focus on molecular residual disease testing in the curative intent setting.